|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-4-11
|
|
pubmed:abstractText |
Quetiapine (ICI 204,636, 'Seroquel') is a new atypical antipsychotic agent with a similar binding profile to the original atypical antipsychotic, clozapine. Its clinical efficacy has already been demonstrated at multiple fixed doses (150-750 mg/day) and has been suggested to be comparable with haloperidol (12 mg/day).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0033-2917
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
95-105
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10722180-Adult,
pubmed-meshheading:10722180-Antipsychotic Agents,
pubmed-meshheading:10722180-Dibenzothiazepines,
pubmed-meshheading:10722180-Dose-Response Relationship, Drug,
pubmed-meshheading:10722180-Double-Blind Method,
pubmed-meshheading:10722180-Female,
pubmed-meshheading:10722180-Haloperidol,
pubmed-meshheading:10722180-Humans,
pubmed-meshheading:10722180-Male,
pubmed-meshheading:10722180-Middle Aged,
pubmed-meshheading:10722180-Schizophrenia,
pubmed-meshheading:10722180-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
|
|
pubmed:affiliation |
Mental Health Research Intstitute of Victoria, Parkville, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
